Mondana H Ghias
Overview
Explore the profile of Mondana H Ghias including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
86
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Babbush Graber K, Ghias M, Andriano T, Cohen J, Zhu T, Hosgood H, et al.
J Am Acad Dermatol
. 2024 May;
91(3):527-529.
PMID: 38704037
No abstract available.
2.
Burshtein J, Buethe M, Ghias M, Buros Stein A, Glick S, Marmon S
JAAD Int
. 2023 May;
12:3-11.
PMID: 37228364
Background: The use of teledermatology abruptly expanded with the arrival of COVID-19. Here, we review recent studies regarding the efficacy, perception, and utilization of telemedicine in the pediatric population. Objective:...
3.
Ghias M, Johnston A, Babbush K, Kutner A, Hosgood H, Lowes M, et al.
J Am Acad Dermatol
. 2021 Apr;
86(4):954-956.
PMID: 33812958
No abstract available.
4.
Ghias M, Johnston A, Kutner A, Micheletti R, Hosgood H, Cohen S
J Am Acad Dermatol
. 2020 Nov;
84(4):e203-e204.
PMID: 33253838
No abstract available.
5.
Ghias M, Amin B, Kutner A
JAAD Case Rep
. 2020 Jan;
6(1):54-56.
PMID: 31909140
No abstract available.
6.
Ghias M, Hyde M, Tomalin L, Morgan B, Alavi A, Lowes M, et al.
J Invest Dermatol
. 2019 Dec;
140(3):531-536.e1.
PMID: 31870626
Although the role of immune dysregulation in hidradenitis suppurativa (HS) has yet to be elucidated, recent studies identified several complement abnormalities in patients with HS. The complement system serves a...
7.
Ghias M, Johnston A, Kutner A, Micheletti R, Hosgood H, Cohen S
J Am Acad Dermatol
. 2019 Oct;
82(5):1094-1101.
PMID: 31589948
Background: The permanent disfigurement associated with hidradenitis suppurativa (HS) necessitates early aggressive disease intervention. Although limited data support the use of infliximab (IFX) in HS, the efficacy of high-dose, high-frequency...
8.
Ghias M, Shamloul N, Khachemoune A
Acta Dermatovenerol Alp Pannonica Adriat
. 2019 Sep;
28(3):113-117.
PMID: 31545388
Several common practices and widely accepted principles implemented in dermatologic surgery are based on perpetuated beliefs not supported by evidence-based medicine. After evaluating the validity of misconceptions in dermatologic surgery,...
9.
Shamloul N, Ghias M, Khachemoune A
Int J Low Extrem Wounds
. 2019 Jun;
18(3):228-235.
PMID: 31198071
Appropriate management of both acute and chronic wounds is a dynamic practice that consumes large amounts of time and financial resources within the health care system. Traditionally, wounds were measured...
10.
Hoffman L, Ghias M, Garg A, Hamzavi I, Alavi A, Lowes M
Semin Cutan Med Surg
. 2017 May;
36(2):86-92.
PMID: 28538750
Hidradenitis suppurativa (HS) is a complex dermatological disease characterized by recurrent painful nodules and suppuration in areas such as the axilla and groin. The disease is poorly understood and treatment...